SCHEMBL30587368

SCHEMBL30587368

Cn1c(=O)[nH]c2ccc(F)c(F)c21

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 4/20 0.64
LMNA P02545 2/20 0.43
PGR P06401 6/20 0.41
ADORA3 P0DMS8 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA2B P29275 1/20 0.41
ADORA1 P30542 1/20 0.41
DPP4 P27487 1/20 0.40
MEN1 O00255 1/20 0.39
PABPC1 P11940 1/20 0.39
KMT2A Q03164 1/20 0.39
MAOB P27338 1/20 0.38
KDM4E B2RXH2 1/20 0.37
GAA P10253 1/20 0.37
BRD4 O60885 1/20 0.37
CSNK2A2 P19784 1/20 0.35
CSNK2B P67870 1/20 0.35
CSNK2A1 P68400 1/20 0.35
PDE3B Q13370 1/20 0.35
PDE3A Q14432 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16883536 1.00 DAO (0.64) DAOLMNAPGRADORA3ADORA2A
SCHEMBL16883537 0.84 DAO (0.49) DAOLMNAPGRADORA3ADORA2A
SCHEMBL31731636 0.82 DAO (0.44) DAOLMNAPGRADORA3ADORA2A
SCHEMBL29751458 0.82 DAO (0.47) DAOLMNAPGRADORA3ADORA2A
SCHEMBL25036216 0.82 DAO (0.44) DAOLMNAPGRADORA3ADORA2A
SCHEMBL24058145 0.82 DAO (0.47) DAOLMNAPGRADORA3ADORA2A
SCHEMBL20079380 0.81 DAO (0.58) DAOPGRMAOB
SCHEMBL14992295 0.80 DAO (0.41) DAOLMNAADORA3ADORA2AADORA2B
SCHEMBL16883535 0.80 DAO (0.45) DAOLMNAPGRADORA3ADORA2A
SCHEMBL16883679 0.78 PGR (0.46) DAOLMNAPGRADORA3ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240150287-A1 N-(BENZOYL)-PHENYLALANINE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF HANGZHOU APELOA MEDICINE RESEARCH INSTITUTE CO., LTD. (CN) 2024-05-09 US disclosed
CN-116997550-A N- (benzoyl) -phenylalanine compounds, pharmaceutical compositions containing same and application thereof 杭州普洛药物研究院有限公司 2023-11-03 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240150287-A1 N-(BENZOYL)-PHENYLALANINE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF ITGB7, ITGB4, ITGA4 DAO 655/4885LMNA 2583/4885PGR 1569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.